Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management with an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both

Charles V. Pollack, Deborah B. Diercks, Stephen H. Thomas, Nathan I. Shapiro, John Fanikos, Sharon E. Mace, Zubaid Rafique, Knox H. Todd

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives Patient compliance and satisfaction with analgesics prescribed after emergency department (ED) care for acute pain are poorly understood, largely because of the lack of direct patient follow-up with the ED provider. Our objective was to compare patient satisfaction with three analgesia regimens prescribed for post-ED care - a nasally administered nonsteroidal anti-inflammatory drug (NSAID), an opioid, or combination therapy - by collecting granular follow-up on analgesic use, pain scores, side effects, work activity levels, and overall satisfaction directly from patients. Methods We designed a prospective registry linking ED assessment and analgesic management for acute pain of specific musculoskeletal or visceral etiologies with self-reported automated telephonic follow-up daily for the 4 days post-ED discharge. Patients were prescribed a specific NSAID (SPRIX, ketorolac tromethamine for nasal instillation) only, an oral opioid only, or both with the opioid clearly defined as rescue therapy, at the ED provider's discretion. Results There were 824 evaluable subjects. Maximum pain scores improved day to day more effectively with a ketorolac-based approach. Self-reported rates of return to work and work effectiveness were higher with SPRIX than with opioids or combination therapy. Adverse effects of nausea, constipation, drowsiness, and abdominal pain were higher each day among patients taking an opioid; nasal irritation was more common with SPRIX. Overall satisfaction at the end of the follow-up period was higher with SPRIX-based treatment than with opioid monotherapy. Conclusions Automated telephonic follow-up of ED patients prescribed short-term analgesia is feasible. Ketorolac-based analgesia after an ED visit for many acute pain syndromes was associated with favorable patient outcomes and higher satisfaction than opioid-based therapy. SPRIX, an NSAID that is not available over the counter and has a novel delivery approach, may be useful for short-term post-ED outpatient analgesia.

Original languageEnglish (US)
Pages (from-to)331-341
Number of pages11
JournalAcademic Emergency Medicine
Volume23
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Acute Pain
Pain Management
Opioid Analgesics
Observational Studies
Hospital Emergency Service
Anti-Inflammatory Agents
Prospective Studies
Pharmaceutical Preparations
Analgesia
Patient Satisfaction
Ketorolac
Analgesics
Emergency Medical Services
Nose
Ketorolac Tromethamine
Therapeutics
Patient Reported Outcome Measures
Pain
Return to Work
Sleep Stages

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management with an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both. / Pollack, Charles V.; Diercks, Deborah B.; Thomas, Stephen H.; Shapiro, Nathan I.; Fanikos, John; Mace, Sharon E.; Rafique, Zubaid; Todd, Knox H.

In: Academic Emergency Medicine, Vol. 23, No. 3, 01.03.2016, p. 331-341.

Research output: Contribution to journalArticle

Pollack, Charles V. ; Diercks, Deborah B. ; Thomas, Stephen H. ; Shapiro, Nathan I. ; Fanikos, John ; Mace, Sharon E. ; Rafique, Zubaid ; Todd, Knox H. / Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management with an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both. In: Academic Emergency Medicine. 2016 ; Vol. 23, No. 3. pp. 331-341.
@article{24f7e01983eb4522bfc0893f0aee6bd0,
title = "Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management with an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both",
abstract = "Objectives Patient compliance and satisfaction with analgesics prescribed after emergency department (ED) care for acute pain are poorly understood, largely because of the lack of direct patient follow-up with the ED provider. Our objective was to compare patient satisfaction with three analgesia regimens prescribed for post-ED care - a nasally administered nonsteroidal anti-inflammatory drug (NSAID), an opioid, or combination therapy - by collecting granular follow-up on analgesic use, pain scores, side effects, work activity levels, and overall satisfaction directly from patients. Methods We designed a prospective registry linking ED assessment and analgesic management for acute pain of specific musculoskeletal or visceral etiologies with self-reported automated telephonic follow-up daily for the 4 days post-ED discharge. Patients were prescribed a specific NSAID (SPRIX, ketorolac tromethamine for nasal instillation) only, an oral opioid only, or both with the opioid clearly defined as rescue therapy, at the ED provider's discretion. Results There were 824 evaluable subjects. Maximum pain scores improved day to day more effectively with a ketorolac-based approach. Self-reported rates of return to work and work effectiveness were higher with SPRIX than with opioids or combination therapy. Adverse effects of nausea, constipation, drowsiness, and abdominal pain were higher each day among patients taking an opioid; nasal irritation was more common with SPRIX. Overall satisfaction at the end of the follow-up period was higher with SPRIX-based treatment than with opioid monotherapy. Conclusions Automated telephonic follow-up of ED patients prescribed short-term analgesia is feasible. Ketorolac-based analgesia after an ED visit for many acute pain syndromes was associated with favorable patient outcomes and higher satisfaction than opioid-based therapy. SPRIX, an NSAID that is not available over the counter and has a novel delivery approach, may be useful for short-term post-ED outpatient analgesia.",
author = "Pollack, {Charles V.} and Diercks, {Deborah B.} and Thomas, {Stephen H.} and Shapiro, {Nathan I.} and John Fanikos and Mace, {Sharon E.} and Zubaid Rafique and Todd, {Knox H.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/acem.12902",
language = "English (US)",
volume = "23",
pages = "331--341",
journal = "Academic Emergency Medicine",
issn = "1069-6563",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management with an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both

AU - Pollack, Charles V.

AU - Diercks, Deborah B.

AU - Thomas, Stephen H.

AU - Shapiro, Nathan I.

AU - Fanikos, John

AU - Mace, Sharon E.

AU - Rafique, Zubaid

AU - Todd, Knox H.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Objectives Patient compliance and satisfaction with analgesics prescribed after emergency department (ED) care for acute pain are poorly understood, largely because of the lack of direct patient follow-up with the ED provider. Our objective was to compare patient satisfaction with three analgesia regimens prescribed for post-ED care - a nasally administered nonsteroidal anti-inflammatory drug (NSAID), an opioid, or combination therapy - by collecting granular follow-up on analgesic use, pain scores, side effects, work activity levels, and overall satisfaction directly from patients. Methods We designed a prospective registry linking ED assessment and analgesic management for acute pain of specific musculoskeletal or visceral etiologies with self-reported automated telephonic follow-up daily for the 4 days post-ED discharge. Patients were prescribed a specific NSAID (SPRIX, ketorolac tromethamine for nasal instillation) only, an oral opioid only, or both with the opioid clearly defined as rescue therapy, at the ED provider's discretion. Results There were 824 evaluable subjects. Maximum pain scores improved day to day more effectively with a ketorolac-based approach. Self-reported rates of return to work and work effectiveness were higher with SPRIX than with opioids or combination therapy. Adverse effects of nausea, constipation, drowsiness, and abdominal pain were higher each day among patients taking an opioid; nasal irritation was more common with SPRIX. Overall satisfaction at the end of the follow-up period was higher with SPRIX-based treatment than with opioid monotherapy. Conclusions Automated telephonic follow-up of ED patients prescribed short-term analgesia is feasible. Ketorolac-based analgesia after an ED visit for many acute pain syndromes was associated with favorable patient outcomes and higher satisfaction than opioid-based therapy. SPRIX, an NSAID that is not available over the counter and has a novel delivery approach, may be useful for short-term post-ED outpatient analgesia.

AB - Objectives Patient compliance and satisfaction with analgesics prescribed after emergency department (ED) care for acute pain are poorly understood, largely because of the lack of direct patient follow-up with the ED provider. Our objective was to compare patient satisfaction with three analgesia regimens prescribed for post-ED care - a nasally administered nonsteroidal anti-inflammatory drug (NSAID), an opioid, or combination therapy - by collecting granular follow-up on analgesic use, pain scores, side effects, work activity levels, and overall satisfaction directly from patients. Methods We designed a prospective registry linking ED assessment and analgesic management for acute pain of specific musculoskeletal or visceral etiologies with self-reported automated telephonic follow-up daily for the 4 days post-ED discharge. Patients were prescribed a specific NSAID (SPRIX, ketorolac tromethamine for nasal instillation) only, an oral opioid only, or both with the opioid clearly defined as rescue therapy, at the ED provider's discretion. Results There were 824 evaluable subjects. Maximum pain scores improved day to day more effectively with a ketorolac-based approach. Self-reported rates of return to work and work effectiveness were higher with SPRIX than with opioids or combination therapy. Adverse effects of nausea, constipation, drowsiness, and abdominal pain were higher each day among patients taking an opioid; nasal irritation was more common with SPRIX. Overall satisfaction at the end of the follow-up period was higher with SPRIX-based treatment than with opioid monotherapy. Conclusions Automated telephonic follow-up of ED patients prescribed short-term analgesia is feasible. Ketorolac-based analgesia after an ED visit for many acute pain syndromes was associated with favorable patient outcomes and higher satisfaction than opioid-based therapy. SPRIX, an NSAID that is not available over the counter and has a novel delivery approach, may be useful for short-term post-ED outpatient analgesia.

UR - http://www.scopus.com/inward/record.url?scp=84960424967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960424967&partnerID=8YFLogxK

U2 - 10.1111/acem.12902

DO - 10.1111/acem.12902

M3 - Article

AN - SCOPUS:84960424967

VL - 23

SP - 331

EP - 341

JO - Academic Emergency Medicine

JF - Academic Emergency Medicine

SN - 1069-6563

IS - 3

ER -